Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1P30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,239
Award facts
- Contract value 100% obligated
- $55,239.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $55,239.30 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units). This competitive delivery order, issued on December 12, 2025 with completion scheduled for December 15, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates established capability as a critical federal medical procurement vendor through its comprehensive portfolio of pharmaceutical deliveries to military and veteran healthcare systems. The company's IDC vehicle serves as a global pharmaceutical support platform enabling supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Xifaxan, an antibiotic medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F1P30?
SPE2DR26F1P30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F1P30 worth?
The government has obligated $55,239 on SPE2DR26F1P30.
Is contract SPE2DR26F1P30 an order under another contract?
Yes. SPE2DR26F1P30 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1P30 competed?
The extent of competition for SPE2DR26F1P30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award